Eric Pauwels insider trades: Ptc Therapeutics (PTCT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Eric reports to the SEC
Open-market buys and sales
30 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | PTCT | ↓ Sell | 21,277 | $75.00 | $1.6M | Direct | Jun 12, 2026 (2d) |
| Feb 18, 2026 | PTCT | ↓ Sell | 3,019 | $69.36 | $209K | Direct | Feb 20, 2026 (2d) |
| Jan 12, 2026 | PTCT | ↓ Sell | 7,348 | $77.02 | $566K | Direct | Jan 12, 2026 (0d) |
| Jan 7, 2026 | PTCT | ↓ Sell | 3,141 | $77.18 | $242K | Direct | Jan 8, 2026 (1d) |
| Dec 19, 2025 | PTCT | ↓ Sell | 20,508 | $77.26 | $1.6M | Direct | Dec 23, 2025 (4d) |
| Dec 18, 2025 | PTCT | ↓ Sell | 43,392 | $75.40 | $3.3M | Direct | Dec 19, 2025 (1d) |
| Sep 8, 2025 | PTCT | ↓ Sell | 39,850 | $56.92 | $2.3M | Direct | Sep 9, 2025 (1d) |
| Mar 17, 2025 | PTCT | ↓ Sell | 11,220 | $56.16 | $630K | Direct | Mar 18, 2025 (1d) |
| Feb 20, 2025 | PTCT | ↓ Sell | 2,945 | $50.11 | $148K | Direct | Feb 21, 2025 (1d) |
| Jan 8, 2025 | PTCT | ↓ Sell | 3,735 | $44.86 | $168K | Direct | Jan 10, 2025 (2d) |
| Apr 17, 2024 | PTCT | ↓ Sell | 787 | $25.14 | $20K | Direct | Apr 19, 2024 (2d) |
| Jan 30, 2024 | PTCT | ↓ Sell | 366 | $27.25 | $10K | Direct | Feb 1, 2024 (2d) |
| Jan 9, 2024 | PTCT | ↓ Sell | 3,634 | $28.85 | $105K | Direct | Jan 10, 2024 (1d) |
| May 22, 2023 | PTCT | ↓ Sell | 8,416 | $58.97 | $496K | Direct | May 23, 2023 (1d) |
| May 18, 2023 | PTCT | ↓ Sell | 8,836 | $58.52 | $517K | Direct | May 19, 2023 (1d) |
| Apr 18, 2023 | PTCT | ↓ Sell | 732 | $52.04 | $38K | Direct | Apr 20, 2023 (2d) |
| Jan 31, 2023 | PTCT | ↓ Sell | 375 | $45.63 | $17K | Direct | Feb 2, 2023 (2d) |
| Jan 24, 2023 | PTCT | ↓ Sell | 359 | $47.45 | $17K | Direct | Jan 26, 2023 (2d) |
| Jan 11, 2023 | PTCT | ↓ Sell | 1,234 | $43.59 | $54K | Direct | Jan 12, 2023 (1d) |
| Jan 9, 2023 | PTCT | ↓ Sell | 858 | $41.66 | $36K | Direct | Jan 11, 2023 (2d) |
| Apr 19, 2022 | PTCT | ↓ Sell | 822 | $42.52 | $35K | Direct | Apr 21, 2022 (2d) |
| Feb 1, 2022 | PTCT | ↓ Sell | 367 | $40.00 | $15K | Direct | Feb 3, 2022 (2d) |
| Jan 25, 2022 | PTCT | ↓ Sell | 359 | $39.31 | $14K | Direct | Jan 27, 2022 (2d) |
| Jan 7, 2022 | PTCT | ↓ Sell | 866 | $38.52 | $33K | Direct | Jan 11, 2022 (4d) |
| Jan 4, 2022 | PTCT | ↓ Sell | 806 | $41.16 | $33K | Direct | Jan 6, 2022 (2d) |
| Apr 19, 2021 | PTCT | ↓ Sell | 786 | $48.17 | $38K | Direct | Apr 21, 2021 (2d) |
| Feb 1, 2021 | PTCT | ↓ Sell | 362 | $56.96 | $21K | Direct | Feb 2, 2021 (1d) |
| Jan 25, 2021 | PTCT | ↓ Sell | 431 | $62.05 | $27K | Direct | Jan 27, 2021 (2d) |
| Jan 5, 2021 | PTCT | ↓ Sell | 1,067 | $62.37 | $67K | Direct | Jan 7, 2021 (2d) |
| Nov 3, 2020 | PTCT | ↓ Sell | 6,194 | $56.50 | $350K | Direct | Nov 5, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PTCT insiders
Open-market trades in the last 12 months
About Eric Pauwels's insider trades
Eric Pauwels is Chief Business Officer at Ptc Therapeutics (PTCT). Since Nov 3, 2020, Eric has reported no open-market purchases and 30 sales worth $12.6M on SEC Form 4. In the last 12 months: 6 sales ($7.5M).
Their filings also include grants and awards (15 filings), option exercises (7 filings), other transactions (6 filings), shares withheld for taxes (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PTCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.